Barriers to Implementing SMART for Asthma in Pediatric Primary Care.

OBJECTIVES: To characterize awareness, use, and perceived barriers to implementing single maintenance and reliever therapy (SMART) in primary care for children aged 5 years or older, hypothesizing high clinician awareness but limited use due to multilevel clinician-, system-, and caregiver barriers....

Full description

Bibliographic Details
Published in:Pediatrics Vol. 158; no. 2; pp. 1 - 2
Main Authors: Peled, Julia, Dodd, Sherry, Graham, Sharon, Wang, Ruoyun, Rook, Shannon, Plax, Katie, James, Aimee S., Harris, Kelly, King, Allison A., Krings, James G.
Format: pictorial research tables/charts Journal Article
Published: American Academy of Pediatrics Aug2026
Online Access:View this record in EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=195830999&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 195830999
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        00314005
        PDT
      jtl: Pediatrics
      issn: 00314005
      maglogo: N
    pubinfo:
      dt: Aug2026
      vid: 158
      iid: 2
      pid: 1659
      pub: American Academy of Pediatrics
      place: Elk Grove Village, Illinois
    artinfo:
      ui:
        195830999
        195830999
        195830999
        10.1542/peds.2026-076324
        195830999
      ppf: 1
      ppct: 1
      formats:
      tig:
        atl: Barriers to Implementing SMART for Asthma in Pediatric Primary Care.
      aug:
        au:
          Peled, Julia
          Dodd, Sherry
          Graham, Sharon
          Wang, Ruoyun
          Rook, Shannon
          Plax, Katie
          James, Aimee S.
          Harris, Kelly
          King, Allison A.
          Krings, James G.
        affil: Division of Allergy and Pulmonology, Department of Pediatrics, Washington University School of Medicine in St. Louis, St. Louis, Missouri
      sug:
        subj:
          Asthma Drug Therapy
          Pediatric Care
          Primary Health Care
          Bronchodilator Agents Therapeutic Use
          Program Implementation
          Human
          Multimethod Studies
          Prescribing Patterns
          Semi-Structured Interview
          Purposive Sample
          Attitude of Health Personnel
          Workflow
          Insurance Coverage
          Caregiver Burden
          Audit
          Feedback
          Implementation Science
          Adrenergic beta-Agonists Therapeutic Use
          Nebulizers and Vaporizers
          Caregiver Attitudes
          Child
          Child: 6-12 years
      ab: OBJECTIVES: To characterize awareness, use, and perceived barriers to implementing single maintenance and reliever therapy (SMART) in primary care for children aged 5 years or older, hypothesizing high clinician awareness but limited use due to multilevel clinician-, system-, and caregiver barriers. METHODS: We conducted a sequential explanatory mixed-methods study among pediatric primary care clinicians within a practice-based research network. Clinicians completed a survey assessing SMART awareness, prescribing practices, and perceived barriers, guided by the Consolidated Framework for Implementation Research (CFIR) 2.0. Semistructured interviews were conducted with purposively sampled clinicians to explore factors influencing SMART implementation. Qualitative data were analyzed using an inductive-deductive approach and mapped to CFIR 2.0 constructs. RESULTS: Fifty-two clinicians (27.5%) completed the survey, and 24 completed interviews. Awareness of SMART was universal, but use remained limited among eligible pediatric patients, particularly younger children. Clinicians viewed SMART as effective and guideline-concordant but described multilevel barriers to routine implementation. Qualitative analysis identified 3 themes: (1) SMART is clinically advantageous but challenging to operationalize; (2) system-level and workflow barriers, including insurance coverage and prior authorization requirements, constrain adoption; and (3) caregiver resistance impedes deimplementation of short-acting β-agonists. Absence of SMART-specific asthma action plans emerged as a key barrier across care settings. CONCLUSION: Pediatric primary care clinicians endorse SMART therapy but face persistent clinician-, system-, and caregiver-level barriers to its implementation and to the deimplementation of short-acting β-agonists. Implementation strategies incorporating practice facilitation, audit and feedback, and electronic health record–generated SMART-specific asthma action plans may support more consistent uptake of pediatric guideline–concordant asthma care.
      pubtype: Academic Journal
      doctype:
        pictorial
        research
        tables/charts
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N